Cargando…

Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study)

PURPOSE: To assess generalized (GD) and focal ellipsoid zone disruption (FD) in patients with symptomatic vitreomacular adhesion (sVMA) using spectral domain optical coherence tomography (SD-OCT) following ocriplasmin. PATIENTS AND METHODS: OZONE was a Phase 4, retrospective study of patients with s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drenser, Kimberly A, Pieramici, Dante J, Gunn, Joseph M, Rosberger, Daniel F, Kozma, Petra, Fineman, Mitchell S, Duchateau, Luc, Khanani, Arshad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Clinical Trial Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291832/ https://www.ncbi.nlm.nih.gov/pubmed/34295149 http://dx.doi.org/10.2147/OPTH.S285464

Ejemplares similares

Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema
por: Dugel, Pravin U., et al.
Publicado: (2021)

Retinal breaks due to intravitreal ocriplasmin
por: Silva, Ruwan A, et al.
Publicado: (2014)

Rhegmatogenous retinal detachment following intravitreal ocriplasmin
por: Madi, Haifa A., et al.
Publicado: (2016)

PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY
por: Mein, Calvin, et al.
Publicado: (2020)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
por: Casswell, Edward, et al.
Publicado: (2014)

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

Myopic macular hole detachment associated with intravitreal ocriplasmin
por: Goh, Li Yen, et al.
Publicado: (2020)

OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study
por: Steel, David H. W., et al.
Publicado: (2020)

Cooling Anesthesia for Intravitreal Injection: Results of the Prospective Open-Label, Dose-Ranging COOL-1 Trial
por: Chao, Daniel L, et al.
Publicado: (2021)

Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
por: Jackson, Timothy L., et al.
Publicado: (2017)

Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection
por: Chow, Nicholas, et al.
Publicado: (2018)

THE OASIS MP-1 SUBSTUDY: Characterization of the Effect of Ocriplasmin on Microperimetry Parameters
por: Sadda, SriniVas R., et al.
Publicado: (2019)

Effectiveness of ocriplasmin in real‐world settings: A systematic literature review, meta‐analysis, and comparison with randomized trials
por: Khanani, Arshad M., et al.
Publicado: (2020)

Transient visual loss and delayed resolution of vitreomacular traction after intravitreal ocriplasmin
por: DaCosta, Joanna, et al.
Publicado: (2014)

Lowered intraocular pressure in a glaucoma patient after intravitreal injection of ocriplasmin
por: McClintock, Michael, et al.
Publicado: (2015)

Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment
por: Arrigo, Alessandro, et al.
Publicado: (2020)

Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial
por: Velaga, Swetha Bindu, et al.
Publicado: (2021)

Ocriplasmin for Vitreoretinal Diseases
por: Tsui, Irena, et al.
Publicado: (2012)

Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies
por: Joondeph, Brian C., et al.
Publicado: (2021)

Intravitreal ocriplasmin for the treatment of vitreomacular traction and macular hole- A study of efficacy and safety based on NICE guidance
por: Muqit, Mahiul M. K., et al.
Publicado: (2018)

Intraobserver Repeatability and Interobserver Reproducibility of Ellipsoid Zone Measurements in Retinitis Pigmentosa
por: Strampe, Margaret R., et al.
Publicado: (2018)

EVALUATION OF FULL-FIELD ELECTRORETINOGRAM REDUCTIONS AFTER OCRIPLASMIN TREATMENT: Results of the OASIS Trial ERG Substudy
por: Birch, David G., et al.
Publicado: (2018)

Ocriplasmin: who is the best candidate?
por: Prospero Ponce, Claudia M, et al.
Publicado: (2016)

Reduced perfusion density of superficial retinal capillary plexus after intravitreal ocriplasmin injection for idiopathic vitreomacular traction
por: Iuliano, Lorenzo, et al.
Publicado: (2019)

Ocriplasmin for Treatment of Vitreomacular Traction: An Update
por: Khan, Mohammed Ali, et al.
Publicado: (2016)

Validating Ellipsoid Zone Area Measurement With Multimodal Imaging in Choroideremia
por: Zhai, Yi, et al.
Publicado: (2021)

Relative Ellipsoid Zone Reflectivity in Macular Telangiectasia Type 2
por: Goerdt, Lukas, et al.
Publicado: (2023)

Ellipsoidal InAs Quantum Dots
por: Sablon, KimberlyAnnosha
Publicado: (2009)

Cooling Anesthesia for Intravitreal Injections – A Review
por: Chandrasekaran, Priya R, et al.
Publicado: (2023)

Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics
por: Bertelmann, Thomas, et al.
Publicado: (2021)

Correlation of Macular Focal Electroretinogram with Ellipsoid Zone Extension in Stargardt Disease
por: Abed, Edoardo, et al.
Publicado: (2017)

Focus on external limiting membrane and ellipsoid zone in diabetic macular edema
por: Saxena, Sandeep, et al.
Publicado: (2021)

Italian real-life experience on the use of ocriplasmin
por: Barca, Francesco, et al.
Publicado: (2018)

FitEllipsoid: a fast supervised ellipsoid segmentation plugin
por: Kovac, Bastien, et al.
Publicado: (2019)

Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone in Childhood-Onset Stargardt Disease
por: Tanna, Preena, et al.
Publicado: (2019)

Challenges Associated With Ellipsoid Zone Intensity Measurements Using Optical Coherence Tomography
por: Lee, Karen E., et al.
Publicado: (2021)

Profile of ocriplasmin and its potential in the treatment of vitreomacular adhesion
por: Stefanini, Francisco R, et al.
Publicado: (2014)

A prospective pilot study comparing combined intravitreal ranibizumab and half-fluence photodynamic therapy with ranibizumab monotherapy in the treatment of neovascular age-related macular degeneration
por: Williams, Patrick D, et al.
Publicado: (2012)

OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study
por: Runkle, Anne P., et al.
Publicado: (2017)

Comparison of Two Different Intravitreal Injection Techniques
por: Uy, Harvey S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9vocv8t5mpheg5smfvvdt7si5j